Helicon Group Limited

HELICON GROUP LIMITED (ASX: HCG) signed a cooperation agreement with Jewim Pharmaceuticals Inc, a leading player in the Chinese pharmaceutical industry.

HELICON GROUP LIMITED (ASX code: HCG) announced the release of its 2007 Annual Report, the first as a publicly listed company.

HELICON GROUP LIMITED (ASX: HCG) announced today that the Chinese regulatory authority, the State Food and Drug Administration (SFDA) has formally accepted Helicon's dossier seeking marketing approval for the China market for ReCell(R).

HELICON GROUP LIMITED (ASX: HCG) announced today the relocation of its CEO, Mr Peter Abrahamson to Shanghai to oversee the implementation of its China Strategy.